会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明专利
    • Antilipemic agent
    • 抗生素
    • JPS59172488A
    • 1984-09-29
    • JP4654683
    • 1983-03-18
    • Tanabe Seiyaku Co Ltd
    • MATSUMOTO KAZUOTAKASHIMA KOUKI
    • C07D413/04A61K31/42A61P3/06A61P7/02
    • PURPOSE: An antilipemic agent, containing a specific furyloxazolylacetic acid derivative as an active constituent, and having reducing action on blood serum cholesterol and blood serum triglyceride and further inhibitory action on blood platelet agglutination without side effects, e.g. hepatic function disorder, etc.
      CONSTITUTION: An antilipemic agent containing a furyloxazolylacetic acid derivative (salt) of formula I [R
      1 is 1W6C alkyl, 5W6C cycloalkyl or (substituted) phenyl; R
      2 is H or 1W12C alkyl] as an active constituent. The compound of formula I (group R
      2 is R
      3 ) can be prepared by cyclizing a 3-acylaminopropionic acid derivative of formula II (R
      3 is 1W12C alkyl) through dehydration. The antilipemic agent is administered usually in 1W20mg/kg/day dose.
      COPYRIGHT: (C)1984,JPO&Japio
    • 目的:含有特定的呋喃并唑基乙酸衍生物作为活性成分的抗疲劳剂,对血清胆固醇和血清甘油三酸酯具有降低作用,并且对血小板凝集的进一步抑制作用无副作用,例如, 肝功能障碍等。构成:含有式I的呋喃并唑基乙酸衍生物(盐)的抗血药剂[R 1]为1-6C烷基,5-6C环烷基或(取代)苯基; R 2为H或1-12C烷基]作为活性成分。 式I化合物(基团R 2为R 3)可以通过脱水将环状式II的3-酰基氨基丙酸衍生物(R 3为1-12C烷基)环化来制备。 抗疲劳剂通常以1-20mg / kg /天的剂量施用。